Ingen internetforbindelse — viser den gemte version af siden.

INVENTIVA

FREUR
← Til Screeneren

INVENTIVA (PA:IVA) — Biotechnology. Antal børser, hvor selskabets aktier handles: 3. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
inventivapharma.com
Sektor
Healthcare · Biotechnology
Hovedkontor
Daix, France
Administrerende Direktør
Andrew Obenshain
Ansatte
87
Udestående Aktier
236.22 mio.
Free Float
165.57 mio.
Markedsværdi
711.02 mio. EUR
Insidere
12.63%
Institutionelle Investorer
50.05%
Branche (SIC)
Pharmaceutical Preparations
Juridisk Form
K65D
ISIN
FR0013233012
LEI
969500I9Y690B3FZW590
Beskrivelse

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. It develops Lanifibranor, a novel peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. The company also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. Inventiva S.A. was incorporated in 2011 and is headquartered in Daix, France.

annonce

Børser og Tickere

BørsTickerValutaPrisType
PA Euronext ParisIVA primærEUR2.835 +6.38%almindelige aktier
LSE London Stock Exchange0RNK IOBEUR3.1 +0.00%almindelige aktier
US USA StocksIVEVF OTCUSD3.18 -1.24%almindelige aktier

Kurs over 3 Måneder

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Største Ejere

EjerAndelAktierRapportdato
Caligan Partners, LP3.91%8.16 mio.2026-06-30
Samsara BioCapital, LLC3.02%6.31 mio.2026-06-30
Paradigm Biocapital Advi…1.91%4 mio.2026-06-30
Andera Partners1.74%3.63 mio.2026-06-30
Adar1 Capital Management…1.73%3.61 mio.2026-06-30
Millennium Management Ll…1.68%3.51 mio.2026-06-30
Nantahala Capital Manage…1.29%2.69 mio.2026-06-30
Trails Edge Capital Part…1.27%2.66 mio.2026-06-30
Franklin Resources, Inc.1.26%2.64 mio.2026-06-30
Squadron Capital Managem…1.17%2.44 mio.2026-06-30
abrdn World Healthcare F…0.58%1.21 mio.2026-06-30
abrdn Life Sciences Inve…0.52%1.09 mio.2026-06-30
Franklin Strategic Serie…0.49%1.01 mio.2026-07-31
Fidelity Advisor Series…0.33%685 4002026-07-31
Artisan Partners Funds I…0.27%637 8592026-06-30
Simplify Exchange Traded…0.15%313 4832026-06-30
Fidelity Concord Street…0.07%154 4002026-07-31
Fidelity Concord Street…0.07%136 1612026-07-31
Fidelity Rutland Square…0.03%63 6782026-07-31
Blackstone Alternative I…0.02%42 7522026-06-30
Fidelity Concord Street…0.01%29 3002026-07-31
-SSgA SPDR ETFS Europe I…0.01%16 4092026-07-31
-SSgA SPDR ETFS Europe I…0%9 8432026-07-31
-SSgA SPDR ETFS Europe I…0%3 7042026-07-31
DBX ETF Trust-Xtrackers…0%1 3272026-05-31
-Goldman Sachs MSCI Worl…0%3012026-08-31